Larvol Delta - Convergent-Therapeutics-Announces-First-Patient-Treated-in-Phase-II-Clinical-Trial-with-Lead-Therapeutic-Candidate-and-Corporate-Updates

Ac-225 rosopatamab tetraxetan (CONV01-α) - Dominari Holdings

https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-first-patient-treated-in-phase-ii-clinical-trial-with-lead-therapeutic-candidate-and-corporate-updates-302256398.html

Sep 24, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next